| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Immune Therapeutics, Inc. [ IMUN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 05/28/2021 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 05/28/2021 | J(1) | 0 | A | $0 | 429 | D | |||
| Common Stock | 05/28/2021 | J(1) | 0 | A | $0 | 704 | I | By: Griffin Enterprises Group, Inc.(2) | ||
| Common Stock | 05/28/2021 | J(1) | 0 | A | $0 | 2,685 | I | By: Griffin Family Trust(3) | ||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Warrants (Right to Buy) | $5 | 05/28/2021 | J(1) | 0 | 06/30/2017 | 06/26/2032 | Common Stock | 7,420 | $0 | 7,420 | D | ||||
| Convertible Note | $5 | 05/28/2021 | J(1) | 0 | 06/30/2017 | 06/26/2032 | Common Stock | 49,772 | $0 | 49,772 | I | By: Global Reverb Corporation(4) | |||
| Explanation of Responses: |
| 1. The Reporting Person may be deemed to have entered into a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, as of May 28, 2021 in connection with the Reporting Person and the Issuer's execution of a non-binding Term Sheet as of this date in which the Reporting Person executed such Term Sheet as representative of certain other parties to the Term Sheet. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of any securities held by such "group" (and this report shall not be deemed an admission that any such person is the beneficial owner of any such securities), except to the extent of her pecuniary interest, if any, in such securities. |
| 2. 50% owned by the Reporting Person and 50% owned and managed by Robert Wilson, who is the Reporting Person's son, and the Reporting Person has shared voting and dispositive power over such shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the inclusion of these shares in this Form 4 shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 or for any other purpose. |
| 3. An irrevocable trust for the benefit of the Reporting Person's children and grandchildren, and the Reporting Person has shared voting and dispositive power over such shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the inclusion of these shares in this Form 4 shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 or for any other purpose. |
| 4. A Florida corporation, of which Griffin is the sole officer, director and shareholder, and Griffin has sole voting and dispositive power over its securities. |
| /s/ Noreen Griffin | 06/04/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||